Back to DE D. E. Shaw & Co., Inc.

TCRXTCRX
3 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in TSCAN THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 548,402 shares of TCRX (TSCAN THERAPEUTICS INC), worth $537,489 as of 2026-Q2. The position was increased (+71.6% shares). TCRX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$537,489

Current Shares

548,402

Total Value Change

+$468,062

Total Shares Change

+478,975

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
548,402
+71.6%
$537,4890.0%$0.98
36
2026-Q1
Increased
319,587
+360.3%
$322,7830.0%$1.03
38
2025-Q4
New
69,427
-
$69,4270.0%$1.03
32

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used